… PDT for cancer. (b) In therapy to infectious diseases, we will describe the concept of aPDI
and … the new opportunities of aPDI to overcome antibiotic resistance in antimicrobial therapy. …

… to both, but the infectious diseases field must also consider … into separate sections on infectious
diseases and cancer, we … combination drug strategies in infectious diseases. We provide …

… often enhanced during cancer and chronic infections as a … therapeutic target in the treatment
of cancer and also have potential to enhance the efficacy of cancer and infectious disease …

… therapy in cancer, may inform the rational development of therapeutic interventions for infectious
diseases… Although “immunotherapy” is habitually associated with the treatment of cancer…

… results of combination therapies currently quite limited. The results described in this paper
indicate a new direction in the treatment of cancer and infectious diseases. This therapeutical …

… immunologically specific therapeutic modalities mediated by T- … renewed interest in the
therapeutic value of augmenting the … phagocytes in the therapy of cancer and infectious diseases. …

… We counted any infectious diseases occurring at any time after … , “infectious disease” was
defined as any infection requiring … term “infectious disease” was defined as infection requiring …

… more specific focus on infectious diseases (caused by bacteria mainly) and cancer, two of the
… for sensing of cancer biomarkers (speed change and fluorescence switching), cancer and …

… The success of adoptive CAR T cell therapy for cancer has inspired … of infectious diseases.
Here, we review the main achievements in CAR T cell therapy targeting viral infections, …

… prognosis in cancer and infectious diseases. Host-directed therapy (HDT) via immune
checkpoint blockade has revolutionized cancer treatment with therapeutic implications for chronic …